Functional Movement Analysis of Handball Players

March 15, 2018 updated by: Emre Serdar Vayvay, Medipol University

Relationship of Functional Movement Analysis With Injury History and Athletic Parameters In Handball Athletes

RELATIONSHIP OF FUNCTIONAL MOVEMENT ANALYSIS WITH INJURY HISTORY AND ATHLETIC PARAMETERS IN HANDBALL ATHLETES

Abstract Objectives: Handball is a popular sport in many countries. There is lack of knowledge about handball athlete's functional movement capacity. The aim of this study is to investigate the Functional Movement Screen (FMS™) scores, to evaluate the injury risks of handball athletes and to determine its relationship with athletic performance.

Design: Observational study. Methods: A total of 51 professional handball players in Turkey were included in this study. The sport-specific features and demographic data were recorded. The functional movement analysis was performed and agility and balance and force were evaluated.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

In august 2018, same evaluations will be done for same individuals.

Study Type

Interventional

Enrollment (Actual)

51

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 31 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Become a team licensed handball athlete between ages 16-35
  • Have not had a surgical operation involving the musculoskeletal system in the last six months
  • Not having an obstacle to the realization of the tests to be carried out in the study
  • Volunteering to participate in the work

Exclusion Criteria:

  • If feeling any discomfort during the tests
  • Do not want to go on study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Functional Movement Screen
Movement Analysis for injury risk
Other: Functional Movement Screen
Experimental: Vertical Jump Test
Jump test Height Measurement, Functional Movement Screen
Other: Functional Movement Screen
Experimental: Y Balance Test
Functional lower extremity reach with balance, Functional Movement Screen
Other: Functional Movement Screen
Experimental: Illinois Agility Test
Agility measurement, Functional Movement Screen
Other: Functional Movement Screen
No Intervention: Injury History
Athletes injury history for last year was recorded as injury count.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Movement Screen Assessment (FMS)
Time Frame: 20 minutes
0-21 (It has 7 subtests, and minimum 0 and maximum 3 is given for scoring.) Higher scores are better. For bilateral subtests, scoring is performed for both sides, and scoring is given according to lower side. ( Example; Right 2, Left 1 so 1 point score is given for that parameter. At last, all 7 scores summed for total score(0/21).
20 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vertical Jump Test
Time Frame: 5 minutes
Inches, Higher scores are better.
5 minutes
Y Balance Test
Time Frame: 10 minutes
Functional Reach Measurement, higher scores are better.
10 minutes
Illinois Agility Test
Time Frame: 2 minutes
Agility Measurement, Lower scores are better.
2 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Medipol University

Investigators

  • Principal Investigator: Devrim Tarakcı, PhD, Medipol University
  • Study Director: Emre Serdar Vayvay, PhD, Medipol University
  • Study Chair: Candan Algun, PhD,Prof, Medipol University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2016

Primary Completion (Actual)

May 18, 2017

Study Completion (Actual)

May 18, 2017

Study Registration Dates

First Submitted

November 1, 2017

First Submitted That Met QC Criteria

March 15, 2018

First Posted (Actual)

March 16, 2018

Study Record Updates

Last Update Posted (Actual)

March 16, 2018

Last Update Submitted That Met QC Criteria

March 15, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 10840098-604.01.01-E.13036

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sports Physical Therapy

Clinical Trials on Functional Movement Screen

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe